Shanghai ranks Université Paris Cité 3rd

Nov 9, 2023 | Laboratory UTCBS, Research

Here is Shanghai’s thematic ranking for “Pharmaceuticals and Pharmaceutical Sciences”. Shanghai Ranking. UPCité is ranked 3rd just behind Harvard and University College. More information on the Université Paris Cité website Global Ranking of Acad....

Team Vecteur and Materia Nova make the front page of ChemSusChem

Nov 3, 2023 | Laboratory UTCBS, Research

Invited for this month′s cover, the researchers from UTCBS and CiTCoM from Université Paris Cité (Paris, France), as well as Materia Nova (Mons, Belgium). The image emphasizes the deep eutectic solvent preparation thanks to hydrogen bond acceptor and donor...

The Nobel Prize

Oct 5, 2023 | Research

  Nobel Prize of Physiology or Medicine 2023 toKatalin Karikó and Drew Weissman for their discoveries on nucleoside base modifications that enabled the development of effective mRNA vaccines against Covid-19. In an article in the journal Immunity in 2005, Katalin...

Validation of a formulation from UTCBS to reduce recurrence rates after local treatment of colorectal cancer,

Jun 29, 2023 | Laboratory UTCBS, Research

Start-up Imisca and Erganeo have signed an exclusive license for a new gel-forming solution to reduce recurrence rates after local treatment of colorectal cancer, improve patient survival and optimize treatment. Colorectal cancer is one of the most common cancers,...

UTCBS takes part in the 6th NanoMed Workshop in Patras (Greece)

Jun 26, 2023 | Laboratory UTCBS, Seminar, Symposium

From July 10 to 12, 2023, the 6th EMJMD NanoMed Workshop will be held in Patras (Greece) on the theme of positioning Nanomedicine in the post-vaccine RNA-messenger era. The UTCBS is fully involved in this event, with Karine Andrieux and Kair Alhareth, participating to...